"Diagnostisches Leistungsspektrum: EKG Belastungs-EKG Langzeit-EKG Langzeit-Blutdruckmessung Abdomensonographie Echokardiographie Transösophageale Echokardiographie Stress-Echokardiographie Duplexsonographie der extrakraniellen Hirngefäße, derExtremitätenarterien und –venen und der retroperitonealen Gefäße (Nierenarterienstenose) Lungenfunktion Intrakranieller Doppler- und Duplexsonographie Schrittmacherkontrollen einschl. biventrikulärer Systeme und ICDs, Ereignisrekorder Kardiorespiratorische Polygraphie Schlafapnoescreening"

During the past decade, Kardiologische Praxis Papenburg conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kardiologische Praxis Papenburg" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "IQVIA Biotech" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kardiologische Praxis Papenburg" are "Heart Failure" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Kardiologische Praxis Papenburg" in a lesser frequency.

Most popular intervention types in "Kardiologische Praxis Papenburg" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Etripamil" (1 trials), "Evolocumab" (1 trials) and "FDC macitentan/tadalafil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kardiologische Praxis Papenburg" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kardiologische Praxis Papenburg". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kardiologische Praxis Papenburg, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kardiologische Praxis Papenburg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".